May 16, 2024 09:00AM
Feb 29, 2024 09:00AM
Jan 3, 2024 09:00AM
Oct 20, 2023 09:00AM
Sep 18, 2023 09:00AM
Sep 15, 2023 09:00AM
Sep 11, 2023 09:00AM Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia
Aug 16, 2023 08:39AM
Jul 12, 2023 09:00AM
Jun 26, 2023 09:00AM
May 25, 2023 09:00AM
May 22, 2023 09:00AM
May 1, 2023 09:00AM
Apr 20, 2023 09:00AM Therapeutic Solutions International Files to Initiate Phase III Clinical Trial for Acute Respiratory Distress Syndrome (ARDS) Leveraging Positive COVID-19 Data with JadiCell Stem Cell Therapy
Feb 21, 2023 09:00AM
Feb 14, 2023 09:00AM
Jan 30, 2023 09:02AM
Jan 30, 2023 09:00AM
Jan 23, 2023 09:00AM
Dec 5, 2022 09:00AM
Nov 28, 2022 09:00AM Therapeutic Solutions International Granted Broad Patent on Treatment of Neurodegenerative Conditions
Nov 9, 2022 09:00AM
Nov 7, 2022 09:00AM
Oct 27, 2022 09:00AM
Oct 24, 2022 09:00AM
Oct 3, 2022 09:00AM
Sep 12, 2022 09:00AM
Aug 29, 2022 09:00AM Therapeutic Solutions International Develops Gene Silencing Therapy for Acute Respiratory Distress Syndrome
Aug 25, 2022 09:00AM
Aug 12, 2022 09:00AM
Jul 18, 2022 09:00AM
May 27, 2022 09:00AM
May 25, 2022 09:00AM
May 23, 2022 09:00AM
May 12, 2022 09:00AM Phase III Lung Adult Stem Cell Company Announces and Files Patent on Leukine-Induced Myeloid Derived Suppressor Cells and JadiCell™ for Treatment of COPD
May 9, 2022 09:00AM
May 2, 2022 09:00AM
Apr 19, 2022 09:00AM
Mar 30, 2022 01:39PM
Mar 28, 2022 09:15AM
Mar 25, 2022 08:00AM
Mar 7, 2022 08:00AM Therapeutic Solutions International Announces ApoptoCyte Procedure for Enhancing Stem Cell Activity
Dec 28, 2021 01:17PM
Oct 11, 2021 09:00AM
Oct 4, 2021 09:00AM
Sep 22, 2021 09:00AM
Sep 13, 2021 09:00AM
Sep 10, 2021 09:00AM
Aug 30, 2021 09:00AM Therapeutic Solutions International Files Investigational New Drug Application with FDA for Cancer Blood Vessel Targeting Immunotherapy StemVacs-V to Treat Metastatic Breast Cancer
Aug 26, 2021 09:00AM

325,295 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All